(Q41250585)

28 September 2017

1 reference

title

Pathologic consequences of increased angiotensin II activity (English)

1 reference

28 September 2017

C M Ferrario

1

1 reference

28 September 2017

J M Flack

series ordinal

2

1 reference

28 September 2017

publication date

1 November 1996

1 reference

Cardiovascular Drugs and Therapy

28 September 2017

published in

1 reference

28 September 2017

volume

10

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

511-518

1 reference

Expression, genomic organization, and transcription of the mouse angiotensin II type 2 receptor gene

28 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00050990

Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells

21 January 2018

1 reference

12 December 2020

Plasma angiotensin(1-7) immunoreactivity is increased by salt load, water deprivation, and hemorrhage

1 reference

12 December 2020

Neurogenic Component of Chronic Renal Hypertension

1 reference

12 December 2020

The renin angiotensin system: importance in physiology and pathology.

1 reference

12 December 2020

Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack

1 reference

12 December 2020

Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension.

1 reference

12 December 2020

Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene

1 reference

12 December 2020

Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla

1 reference

12 December 2020

Evidence that prolyl endopeptidase participates in the processing of brain angiotensin

1 reference

12 December 2020

Kinin antagonist reverses converting enzyme inhibitor-stimulated vascular prostaglandin I2 synthesis

1 reference

12 December 2020

Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure.

1 reference

12 December 2020

Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease

1 reference

12 December 2020

Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.

1 reference

12 December 2020

Angiotensin II-forming pathways in normal and failing human hearts

1 reference

12 December 2020

Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture

1 reference

12 December 2020

Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats

1 reference

12 December 2020

Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence

1 reference

12 December 2020

Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension

1 reference

12 December 2020

Short report: HYPERGENE: a clinical and genetic database for genetic analysis of human hypertension.

1 reference

12 December 2020

The importance of the renin-angiotensin system in reversal of left ventricular hypertrophy

1 reference

12 December 2020

Neurogenic actions of angiotensin II.

1 reference

12 December 2020

Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats

1 reference

12 December 2020

Angiotensin I and II. Some early observations made at the Cleveland Clinic Foundation and recent discoveries relative to angiotensin II formation in human heart

1 reference

12 December 2020

Clinical Experience With Angiotensin II Receptor Antagonists

1 reference

12 December 2020

Central nervous system mechanisms of blood pressure control in normotensive and hypertensive states

1 reference

12 December 2020

Molecular basis of human hypertension: role of angiotensinogen

1 reference

12 December 2020

Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report

1 reference

12 December 2020

Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats

1 reference

12 December 2020

Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension

1 reference

12 December 2020

The renin-angiotensin system: importance in physiology and pathology

1 reference

12 December 2020

Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart

1 reference

12 December 2020

Angiotensin II receptors and angiotensin II receptor antagonists.

1 reference

12 December 2020

The sympathetic system in hypertension. State-of-the-art review

1 reference

12 December 2020

Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7)

1 reference

12 December 2020

The angiotensin I converting enzyme gene and predisposition to high blood pressure

1 reference

12 December 2020

Angiotensin II receptor antagonists: a new approach to blockade of the renin-angiotensin system.

1 reference

12 December 2020

Physiological and pharmacological characterization of the area postrema pressor pathways in the normal dog

1 reference

12 December 2020

Hypertensive mechanisms and converting enzyme inhibitors.

1 reference

12 December 2020

AT4 receptor binding characteristics: D-amino acid- and glycine-substituted peptides

1 reference

12 December 2020

The L-arginine: nitric oxide pathway, cellular transduction and immunological roles

1 reference

12 December 2020

Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes

1 reference

12 December 2020

Transcriptional regulation of the mouse angiotensin II type 2 receptor gene

1 reference

12 December 2020

Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

1 reference

12 December 2020

Natriuretic action of angiotensin(1-7)

1 reference

12 December 2020

Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate

1 reference

12 December 2020

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

1 reference

12 December 2020

Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart

1 reference

12 December 2020

Determinants of angiotensin II generation during converting enzyme inhibition

1 reference

12 December 2020

Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor

1 reference

12 December 2020

Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart

1 reference

12 December 2020

Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension

1 reference

12 December 2020

Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma

1 reference

12 December 2020

The interrelationships among filtration surface area, blood pressure, and chronic renal disease

1 reference

12 December 2020

Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor

1 reference

12 December 2020

Nitric oxide: physiology, pathophysiology, and pharmacology

1 reference

12 December 2020

Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line

1 reference

12 December 2020

Cardiovascular actions of angiotensin(1-7)

1 reference

12 December 2020

Enzymes of the Renin-Angiotensin System and their Inhibitors

1 reference

12 December 2020

Metabolism of substance P and bradykinin by human neutrophils

1 reference

12 December 2020

The Mosaic Theory of Arterial Hypertension—: Its Interpretation

1 reference

12 December 2020

Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart

1 reference

12 December 2020

Angiotensin II Receptors and Functional Correlates

1 reference

12 December 2020

Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study.

1 reference

12 December 2020

The advantages of angiotensin II antagonism

1 reference

12 December 2020

Angiotensin-II receptor subtypes in fetal tissue of the rat: autoradiography, guanine nucleotide sensitivity, and association with phosphoinositide hydrolysis.

1 reference

12 December 2020

Angiotensin II receptor antagonism in ovine heart failure: acute hemodynamic, hormonal, and renal effects

1 reference

12 December 2020

Tissue angiotensin system in cardiovascular medicine. A paradigm shift?

1 reference

12 December 2020

Angiotensin(1-7) in the spontaneously hypertensive rat

1 reference

12 December 2020

Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene

1 reference

12 December 2020

Widespread tissue distribution of human chymase

1 reference

12 December 2020

A new myocardial conversion of angiotensin I.

1 reference

12 December 2020

Cough with angiotensin converting enzyme inhibitors: how much of a problem?

1 reference

12 December 2020

Do primary dysfunctions in neural control of arterial pressure contribute to hypertension?

1 reference

12 December 2020

Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

1 reference

12 December 2020

Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes

1 reference

12 December 2020

Interference of Converting Enzyme Inhibitors with the Kallikrein-Kinin System

1 reference

12 December 2020

Secondary signalling mechanisms in angiotensin II-stimulated vascular smooth muscle cells

1 reference

12 December 2020

Rationale for the Chemical Development of Angiotensin II Receptor Antagonists

1 reference

12 December 2020

Pathways of angiotensin formation and function in the brain

1 reference

12 December 2020

Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension

1 reference

12 December 2020

A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00050990

1 reference

28 September 2017

1 reference